1275526

Celgene Corporation — FEI 3004991673

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 18, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Summit, NJ (United States)